[1]
Kustriyani, A. et al. 2026. Molecular Docking and QSAR Analysis of N-(Ethylcarbamothioyl)benzamide Derivatives as Dual Estrogen-Alpha and Progesterone Receptors Inhibitor for Breast Cancer. Borneo Journal of Pharmacy. 9, 1 (Mar. 2026), 77–87. DOI:https://doi.org/10.33084/bjop.v9i1.10948.